The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis.
other
Where this comes from
- Record sourced from PubMed, PMID 16384756.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval] vs placebo 2.30 [1.26-4.19]). Alefacept provided incremental efficacy over 5 successive 12-week treatment courses.
Medical subject headings
- Psoriasis
- Recombinant Fusion Proteins